Note*: This report requires 5-10 business days to complete.
DelveInsight’s “Nonalcoholic Steatohepatitis (NASH) - Market Insights, Epidemiology and Market Size Forecast-2020” Reports provides an overview of the disease and global market size of the Nonalcoholic Steatohepatitis (NASH) for the United States, EU5 (France, Germany, Italy, Spain, UK) and Japan. It also includes global historical and forecasted epidemiological data for the diagnosed incident cases of Nonalcoholic Steatohepatitis (NASH) from 2010-2020.Steatohepatitis (also known as fatty liver disease) is a type of liver disease, characterized by inflammation of the liver with concurrent fat accumulation in liver. NASH affects 2 to 5 percent of Americans. An additional 10 to 20 percent of Americans have fat in their liver, but no inflammation or liver damage, a condition called “fatty liver.”Most people with NASH are between the ages of 40 and 60 years. Up to 25% of adults with NASH may have cirrhosis. Priorities for future research are the optimization of non-invasive screening strategies, the identification of patients at risk of liver disease progression, the understanding of the hepatic carcinogenic potential and testing innovative pharmacological targets for therapy.
Scope
• Report covers the disease overview including etiology, path physiology, symptoms, diagnosis, disease management, and current treatment options.
• Marketed information including available prescription drugs, its patent and exclusivity details followed by drug sales till 2018.
• The Report also covers the detailed global historical and forecasted epidemiological data covering United States, EU5, Japan and rest of the word from 2010-2020.
• It also provides Market size of Nonalcoholic Steatohepatitis (NASH) for United States, EU5 and Japan from 2010 and forecasted Market size to 2020
'
Table of Contents
• Nonalcoholic Steatohepatitis (NASH)
• Disease overview:
• Pathophysiology:
• Symptoms of disease:
• Etiology of disease
• Diagnosis of disease
• Treatment of disease
• Overview of Marketed drugs
• Drug Description
• Mechanism of Action
• Pharmacokinetics Properties
• Marketed Details
• United States
• Patent Information
• Patent Exclusivity Expiry Assessment United States (US)
• Patents Details
• Historical and Forecasted sales of marketed molecules in the Global Nonalcoholic Steatohepatitis (NASH) Market
• Global Epidemiology of Nonalcoholic Steatohepatitis (NASH) Forecasted to 2020
• Global Market size (2011-2014)
• Global Forecasted Market size (2015-2020)
• Global Market Size by Geography
• Market size of US (2011-2014)
• Forecasted Market size of US (2015-2020)
• Market size of Europe
• Market size of Germany (2011-2014)
• Forecasted Market size of Germany (2015-2020)
• Market size of United Kingdom (2011-2014)
• Forecasted Market size of United Kingdom (2015-2020)
• Market size of France (2011-2014)
• Forecasted Market size of France (2015-2020)
• Market size of Italy (2011-2014)
• Forecasted Market size of Italy (2015-2020)
• Market size of Spain (2011-2014)
• Forecasted Market size of Spain (2015-2020)
• Market size of Japan (2011-2014)
• Forecasted Market Size of Japan (2015-2020)
• Market size of ROW (2011-2014)
• Forecasted Market size of ROW (2015-2020)
• Appendix
• Report Methodology
• Consulting Services
• Disclaimer
• Report Purchase Options
• About DelveInsight
List of Tables
• Table 1: Drug Description
• Table 2: Drug, Marketed Details United States (US)
• Table 3: Drug, Patent Number Specific Patent Expiry in US (Year), 2015
• Table 4: Drug, Patent Details for US
• Table 5: Nonalcoholic Steatohepatitis (NASH) Drug Sales (USD Millions), (2014-2020)
• Table 6: Global Epidemiology of Nonalcoholic Steatohepatitis (NASH) (2011-2020)
• Table 7: Nonalcoholic Steatohepatitis (NASH) Global Market Size (USD Millions), (2011-2014)
• Table 8: Nonalcoholic Steatohepatitis (NASH) Global Market Size (USD Millions), (2015-2020)
• Table 9: Nonalcoholic Steatohepatitis (NASH) US Market Size (USD Millions), (2011-2014)
• Table 10: Nonalcoholic Steatohepatitis (NASH) US Market Size (USD Millions), (2015-2020)
• Table 11: Nonalcoholic Steatohepatitis (NASH) United Kingdom Market Size (USD Millions), (2011-2014)
• Table 12: Nonalcoholic Steatohepatitis (NASH) Germany Market Size (USD Millions), (2015-2020)
• Table 13: Nonalcoholic Steatohepatitis (NASH) United Kingdom Market Size (USD Millions), (2011-2014)
• Table 14: Nonalcoholic Steatohepatitis (NASH) United Kingdom Market Size (USD Millions), (2015-2020)
• Table 15: Nonalcoholic Steatohepatitis (NASH) France Market Size (USD Millions), (2011-2014)
• Table 16: Nonalcoholic Steatohepatitis (NASH) France Market Size (USD Millions), (2015-2020)
• Table 17: Nonalcoholic Steatohepatitis (NASH) Italy Market Size (USD Millions), (2011-2014)
• Table 18: Nonalcoholic Steatohepatitis (NASH) Italy Market Size (USD Millions), (2015-2020)
• Table 19: Nonalcoholic Steatohepatitis (NASH) Spain Market Size (USD Millions), (2011-2014)
• Table 20: Nonalcoholic Steatohepatitis (NASH) Spain Market Size (USD Millions), (2015-2020)
• Table 21: Nonalcoholic Steatohepatitis (NASH) Japan Market Size (USD Millions), (2011-2014)
• Table 22: Nonalcoholic Steatohepatitis (NASH) Japan Market Size (USD Millions), (2015-2020)
• Table 23: Nonalcoholic Steatohepatitis (NASH) ROW Market Size (USD Millions), (2011-2014)
• Table 24: Nonalcoholic Steatohepatitis (NASH) ROW Market Size (USD Millions), (2015-2020)
List of Figures
• Figure 1: Nonalcoholic Steatohepatitis (NASH) Drug Sales (USD Millions), (2011-2014)
• Figure 2: Global Epidemiology of Nonalcoholic Steatohepatitis (NASH) (2011-2020)
• Figure 3: Nonalcoholic Steatohepatitis (NASH) Global Market Size (USD Millions), (2011-2014)
• Figure 4: Nonalcoholic Steatohepatitis (NASH) Global Market Size (USD Millions), (2015-2020)
• Figure 5: Nonalcoholic Steatohepatitis (NASH) US Market Size (USD Millions), (2011-2014)
• Figure 6: Nonalcoholic Steatohepatitis (NASH) US Market Size (USD Millions), (2015-2020)
• Figure 7: Nonalcoholic Steatohepatitis (NASH) Germany Market Size (USD Millions), (2011-2014)
• Figure 8: Nonalcoholic Steatohepatitis (NASH) Germany Market Size (USD Millions), (2015-2020)
• Figure 9: Nonalcoholic Steatohepatitis (NASH) United Kingdom Market Size (USD Millions), (2011-2014)
• Figure 10: Nonalcoholic Steatohepatitis (NASH) United Kingdom Market Size (USD Millions), (2015-2020)
• Figure 11: Nonalcoholic Steatohepatitis (NASH) France Market Size (USD Millions), (2011-2014)
• Figure 12: Nonalcoholic Steatohepatitis (NASH) France Market Size (USD Millions), (2015-2020)
• Figure 13: Nonalcoholic Steatohepatitis (NASH) Italy Market Size (USD Millions), (2011-2014)
• Figure 14: Nonalcoholic Steatohepatitis (NASH) Italy Market Size (USD Millions), (2015-2020)
• Figure 15: Nonalcoholic Steatohepatitis (NASH) Spain Market Size (USD Millions), (2011-2014)
• Figure 16: Nonalcoholic Steatohepatitis (NASH) Spain Market Size (USD Millions), (2015-2020)
• Figure 17: Nonalcoholic Steatohepatitis (NASH) Japan Market Size (USD Millions), (2011-2014)
• Figure 18: Nonalcoholic Steatohepatitis (NASH) Japan Market Size (USD Millions), (2015-2020)
• Figure 19: Nonalcoholic Steatohepatitis (NASH) ROW Market Size (USD Millions), (2011-2014)
• Figure 20: Nonalcoholic Steatohepatitis (NASH) ROW Market Size (USD Millions), (2015-2020)
